Product ID |
Product Name |
CAS# |
Purity |
Y1248867 |
Ruthenocene, (diphenylphosphino)- |
1356191-89-3 |
95% |
Y1239966 |
4-Bromo-1-(3-chlorophenyl)-1H-imidazole |
1363253-90-0 |
98% |
Y1244521 |
4-Bromo-1-(3-bromophenyl)-1H-imidazole |
1363253-98-8 |
97% |
Y1240012 |
4-Bromo-1-(3-bromophenyl)-1H-pyrazole |
1363254-08-3 |
98% |
Y1248868 |
4-Isopropyl-6-methylpyrimidin-5-amine |
1368911-16-3 |
98% |
Y1244558 |
3-Acetyl-4-methoxypyridin-2(1H)-one |
1393566-72-7 |
98% |
Y1253298 |
6-Bromo-5-(2-oxopropyl)benzo[d]oxazol-2(3H)-one |
1398496-40-6 |
98% |
Y3144290 |
1,4-Bis(4-carboxybenzyl)-1-methylpiperazin-1-ium (Imatinib Impurity) |
1407229-73-5 |
97% |
Y1244470 |
(S)-1,2-Diphenylethanamine hydrochloride |
14149-00-9 |
98% |
Y1248926 |
6-((tert-Butoxycarbonyl)amino)-2-fluoronicotinic acid |
1445962-38-8 |
98% |
Y1253371 |
4-Fluoro-5-methyl-1H-pyrrolo[2,3-b]pyridine |
1449321-44-1 |
97% |
Y1244441 |
N-(3-Chloro-2-fluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity) |
1454307-45-9 |
95% |
Y1244471 |
1H-Benzo[d]imidazole-2,7-diamine |
1467571-35-2 |
97% |
Y1253300 |
4,6-Dichloro-2-(1-methylcyclopropyl)pyrimidine |
1542557-31-2 |
98% |
Y1248869 |
N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity) |
1562180-31-7 |
98% |
Y1244443 |
(S)-N-(1-Cyclohexylethyl)-2-methylpropan-1-amine |
1567972-56-8 |
97% |
Y1253363 |
tert-Butyl (3-(bromomethyl)-4-fluorophenyl)carbamate |
1569737-90-1 |
97% |
Y1341175 |
Methyl 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole-3-carboxylate |
1616930-45-0 |
95% |
Y1235134 |
2-((1-Acetyl-3-iodo-1H-indazol-6-yl)thio)-N-methylbenzamide (Axitinib Impurity) |
1639138-00-3 |
97% |
Y1235222 |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (Ibrutinib Impurity) |
1642630-12-3 |
97% |
Y1314752 |
[2'-(Amino-N)[1,1'-biphenyl]-2-yl-C][2'-[(1,1-dimethylethyl)phenylphosphino-P]-N2,N2,N6,N6-tetramethyl[1,1'-biphenyl]-2,6-diamine](methanesulfonato-O)palladium |
1661042-31-4 |
98% |
Y3315744 |
6-Chloro-8-iodoquinolin-2(1H)-one |
1693646-57-9 |
98% |
Y1265883 |
7-Bromo-4,4-difluorochroman |
1783557-72-1 |
97% |
Y1265868 |
2-(6-Bromobenzofuran-3-yl)acetic acid |
1784163-41-2 |
98% |
Y1314638 |
6-Chloro-2-methyl-5-nitro-2H-indazole |
1801267-04-8 |
97% |
Y1235208 |
Br-PEG4-THP |
1803547-60-5 |
97% |
Y1235210 |
Fmoc-(RS)-3-amino-3-(3-trifluoromethylphenyl)-propionic acid |
181953-60-6 |
97% |
Y1235266 |
2-(1-Cyclopropylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane |
1867923-49-6 |
97% |
Y1235224 |
1-(4-Chloro-2,6-difluorophenyl)piperidin-4-one |
1883752-39-3 |
98% |
Y1235211 |
5-Bromo-3-(diethoxymethyl)-1H-pyrazolo[3,4-c]pyridine |
1884158-45-5 |
98% |
Y1235647 |
(R)-3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid |
1957284-71-7 |
98% |
Y1239923 |
N-((4-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide (Palbociclib Impurity) |
198470-91-6 |
97% |
Y1239881 |
1,3-Bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one (Imatinib Impurity) |
1987905-93-0 |
98% |
Y1239882 |
1-(2-Cyano-2-methylpropyl)-1H-pyrazole-5-carboxylic acid |
2029406-44-6 |
97% |
Y1239883 |
1-(2,2,2-Trifluoroethyl)piperazin-2-one hydrochloride |
2098114-26-0 |
97% |
Y3318061 |
6-Bromo-8-iodoquinolin-2(1H)-one |
2101658-56-2 |
98% |
Y1248851 |
8-Methyl-5-(trifluoromethyl)quinolin-2(1H)-one |
2101658-61-9 |
98% |
Y1235661 |
5-Methyl-8-(trifluoromethyl)quinolin-2(1H)-one |
2101658-63-1 |
98% |
Y1239976 |
4-(10H-Phenoxazin-10-yl)benzaldehyde |
2148301-47-5 |
98% |
Y1248852 |
4-Chloro-2-(2,6-dioxopiperidin-3-yl)-1H-pyrrolo[3,4-c]pyridine-1,3(2H)-dione |
2154357-70-5 |
96% |
Y1340294 |
Bromo-PEG4-MS |
2167807-41-0 |
98% |
Y1240003 |
(E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity) |
2170273-17-1 |
97% |
Y1313071 |
2-((S)-4-(7-(8-Chloronaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)piperazin-2-yl)acetonitrile |
2206737-06-4 |
95% |
Y1239978 |
Ethyl 5-amino-4-chloro-2-nitrobenzoate |
2208821-82-1 |
98% |
Y1235650 |
1-Butyl-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine (Ibrutinib Impurity) |
2213398-77-5 |
97% |
Y1239925 |
3-(Hydroxymethyl)-5,5-dimethylpyrrolidin-2-one |
2220206-42-6 |
97% |
Y1244477 |
(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)but-2-enamide (Afatinib Impurity) |
2223677-64-1 |
98% |
Y1248855 |
(S)-N1-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-N2,N2-dimethyloxalamide (Afatinib Impurity) |
2223677-66-3 |
98% |
Y1235133 |
5-((7-Chloro-1H-indol-3-yl)methylene)imidazolidine-2,4-dione |
1627591-09-6 |
95% |
Y1235221 |
2-Amino-6-bromo-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one |
1637781-10-2 |
98% |
Y1235135 |
2,6-Dichloro-8-iodoquinoline |
1702467-60-4 |
97% |
Y1235136 |
N-((3-(5-Methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide (Palbociclib Impurity) |
1709956-89-7 |
97% |
Y1235168 |
2-(((5-(Diethylamino)pentan-2-yl)amino)methyl)-6-methylphenol |
1713897-35-8 |
97% |
Y1235207 |
2-[2-(Morpholine-4-sulfonyl)ethyl]-2,3-dihydro-1H-isoindole-1,3-dione |
173336-67-9 |
97% |
Y1235265 |
2,4-Difluoro-6-methylbenzonitrile |
1803782-57-1 |
98% |
Y1235223 |
2-Amino-5-bromo-1H-benzo[d]imidazol-7-ol |
1804270-43-6 |
98% |
Y1235169 |
Methyl 2-(2-bromo-3,6-difluorophenyl)acetate |
1805594-04-0 |
97% |
Y1235209 |
5-Fluoro-2-iodopyridin-3-ol |
1806294-25-6 |
97% |
Y1235137 |
(R)-8-(1-Acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-3,4-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one (Ibrutinib Impurity) |
1917333-91-5 |
97% |
Y1235660 |
Bromo-PEG2-MS |
1935075-34-5 |
98% |
Y1239939 |
tert-Butyl 2,5,8-triazaspiro[3.5]nonane-2-carboxylate |
1936048-62-2 |
95% |
Y1239880 |
(S)-3-(4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl)propanoic acid |
1957283-54-3 |
98% |
Y1341346 |
tert-Butyl (S)-3-amino-3-(hydroxymethyl)pyrrolidine-1-carboxylate |
2057405-74-8 |
97% |
Y1239975 |
6-((2-Iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione (Tipiracil Impurity) |
2069937-25-1 |
97% |
Y1244418 |
5-Bromo-6-methoxybenzo[b]thiophene-2-carboxylic acid |
2092411-51-1 |
98% |
Y1244419 |
2-(Methylsulfanyl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-thiazole |
2096331-12-1 |
95% |
Y1239940 |
3-Bromo-N-ethyl-2-fluoroaniline |
2109644-24-6 |
97% |
Y1235648 |
N-(3,4-Difluorophenyl)-7-methoxy-6-nitroquinazolin-4-amine (Dacomitinib Impurity) |
2119689-75-5 |
97% |
Y1244474 |
3-Benzyl-2-bromo-9-methyl-4H,6H-thieno[2,3-e][1,2,4]triazolo[3,4-c][1,4]oxazepine |
2126818-91-3 |
98% |
Y1239924 |
2,5-Dioxaspiro[3.4]octan-8-one |
2137714-50-0 |
97% |
Y1235649 |
FmocNH-PEG4-t-butyl ester |
2148295-94-5 |
97% |
Y1239884 |
2-Amino-7-methoxy-1H-benzo[d]imidazole-5-carboxylic acid |
2172017-91-1 |
98% |
Y1248853 |
3-Methyl-5-(pyrrolidin-3-yl)-1H-pyrazole dihydrochloride |
2173135-19-6 |
97% |
Y1239977 |
1-(4-((3-Chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Dacomitinib Impurity) |
2190490-31-2 |
98% |
Y1315074 |
N,N-Diisopropyl-2-(1,1,2,2,2-pentamethyldisilanyl)benzamide |
2204263-18-1 |
98% |
Y1248854 |
1-(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-5-hydroxypyrrolidin-2-one (Afatinib Impurity) |
2223677-58-3 |
98% |
Y1244476 |
(S)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)formamide (Afatinib Impurity) |
2223677-60-7 |
98% |
Y1239885 |
(S,E)-N-(4-((3,4-Difluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity) |
2223677-62-9 |
95% |
Y1239849 |
(S,E)-N-(4-((3,4-Dichlorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity) |
2223677-63-0 |
98% |
Y1240004 |
Methyl 3-(1,2,3,4-tetrahydroisoquinolin-6-yl)propanoate hydrochloride |
2241140-84-9 |
98% |
Y1235651 |
6-Methyl-5-((3-(2-(methylthio)pyrimidin-4-yl)pyridin-2-yl)oxy)naphthalen-1-amine |
2245062-49-9 |
98% |
Y1239886 |
Tert-butyl 6-((4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3,4-dihydroisoquinoline-2(1H)-carboxylate |
2250061-21-1 |
98% |
Y1239887 |
4-(Trifluoromethyl)-1,3-dihydro-2H-benzo[d]imidazol-2-one |
2251-78-7 |
98% |
Y1239948 |
5-Chloro-3-methyl-4-nitro-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazole |
2265200-73-3 |
98% |
Y1239926 |
Fmoc-S-3-amino-4-(3,5-difluorophenyl)-butyric acid |
2349961-71-1 |
98% |
Y1235652 |
tert-Butyl 4-(hydroxymethyl)-2,2-dimethylpyrrolidine-1-carboxylate |
2374131-18-5 |
98% |
Y1239852 |
2-Phenyl-4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine-3-carboxylic acid |
2377032-02-3 |
98% |
Y1244452 |
Benzyl((3aR,4S,6R,6aS)-6-hydroxy-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)carbamate |
2381860-79-1 |
97% |
Y1240007 |
(S)-N4-(4-Fluorophenyl)-7-((tetrahydrofuran-3-yl)oxy)quinazoline-4,6-diamine (Afatinib Impurity) |
2413212-07-2 |
98% |
Y1244495 |
(S,E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(methylamino)but-2-enamide (Afatinib Impurity) |
2413212-13-0 |
95% |
Y1244496 |
2-(Pyrrolidin-3-yl)-1,3,4-thiadiazole dihydrochloride |
2416231-41-7 |
97% |
Y1313487 |
(R)-N-(2-Acetylphenyl)-2-(8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)acetamide (Linagliptin Impurity) |
2416949-69-2 |
98% |
Y1244398 |
2,4-Dichloro-7,7-difluoro-6,7-dihydro-5H-cyclopenta[d]pyrimidine |
2459401-44-4 |
98% |
Y1239928 |
7-(But-2-yn-1-yl)-3-methyl-8-(methylamino)-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione (Linagliptin Impurity) |
2468656-63-3 |
97% |
Y1244399 |
2-(Piperazin-1-ylmethyl)thiazole trihydrochloride |
2470436-38-3 |
95% |
Y1239960 |
3-(Pyrrolidin-1-yl)cyclobutanecarboxylic acid hydrochloride |
2470440-42-5 |
95% |
Y1266402 |
(S,E)-N-(4-((4-Chloro-3-fluorophenyl)amino)-7-((tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide (Afatinib Impurity) |
2475094-87-0 |
98% |
Y1335568 |
tert-Butyl 4-(pyrrolidin-3-yl)piperazine-1-carboxylate hydrochloride |
2624138-75-4 |
97% |
Y1315237 |
(((Chloromethyl)dimethylsilyl)methyl)-4-methylbenzenesulfonamide |
2660240-42-4 |
98% |
Y1266403 |
Fmoc-(RS)-3-amino-3-(4-nitrophenyl)-propionic acid |
273920-31-3 |
97% |